Paxman AB (publ)

SSE:PAX.ST

38.6 (SEK) • At close February 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 63.41358.6255.58961.23350.97442.3245.17641.33835.89327.94429.31823.26922.75820.85718.26317.69417.78724.30822.80822.95321.72417.79418.44516.00412.610.9749.0478.2917.1316.863
Cost of Revenue 52.81251.21551.02519.28316.83112.70216.24311.39911.6619.6129.1128.2058.1756.1928.4276.0375.9916.9095.156.2385.913.9426.4122.8982.1521.0862.4820.1910.4631.769
Gross Profit 10.6017.4054.56441.9534.14329.61828.93329.93924.23218.33220.20615.06414.58314.6659.83611.65711.79617.39917.65816.71515.81413.85212.03313.10610.4489.8886.5658.16.6685.094
Gross Profit Ratio 0.1670.1260.0820.6850.670.70.640.7240.6750.6560.6890.6470.6410.7030.5390.6590.6630.7160.7740.7280.7280.7780.6520.8190.8290.9010.7260.9770.9350.742
Reseach & Development Expenses 0000000000000000001.3140001.1240000.755000
General & Administrative Expenses 000000000000008.29300011.7610000006.2835.8256.5393.1340.065
Selling & Marketing Expenses 00000000000000000000000006.2835.8256.5393.1340.065
SG&A 16.87815.15915.90515.83914.13513.46150.11212.68212.1210.34738.2838.8297.52478.2935.314.5036.97211.7616.1655.9735.94631.6134.9984.7176.2835.8256.5393.1340.065
Other Expenses 17.224000031.27920.19429.14328.11725.22519.82919.85918.40217.0158.10713.88613.49814.3388.59815.42915.20814.08214.19913.32111.224-1.0530.077-2.519-0.475-0.001
Operating Expenses 34.10233.08236.14433.81932.55931.27920.19429.14328.11725.22519.82919.85918.40217.01516.413.88613.49814.33820.35915.42915.20814.08214.19913.32111.22411.51311.72710.5595.7930.333
Operating Income 10.6017.4054.5648.1311.585-1.6618.7390.796-3.885-6.89310.953-4.795-3.819-2.35-6.564-2.229-1.7023.061-2.7011.2860.606-0.23-2.166-0.215-0.776-1.625-5.162-2.4590.875-0.333
Operating Income Ratio 0.1670.1260.0820.1330.031-0.0390.1930.019-0.108-0.2470.374-0.206-0.168-0.113-0.359-0.126-0.0960.126-0.1180.0560.028-0.013-0.117-0.013-0.062-0.148-0.571-0.2970.123-0.049
Total Other Income Expenses Net -0.7635.707-6.587-0.7693.564-0.858-16.3973.8614.5140.7031.675-0.445-1.585-1.306-5.419-2.008-4.721-0.523-0.649-0.439-0.292-0.255-0.12-0.13-0.092-0.0390.14-0.044-0.152-0.005
Income Before Tax 9.83813.112-2.0237.3625.149-2.519-7.6584.6570.629-6.19-1.298-5.24-5.404-3.656-11.983-4.237-6.4232.538-3.350.8470.314-0.485-2.286-0.345-0.868-1.664-5.022-2.5030.723-0.338
Income Before Tax Ratio 0.1550.224-0.0360.120.101-0.06-0.170.1130.018-0.222-0.044-0.225-0.237-0.175-0.656-0.239-0.3610.104-0.1470.0370.014-0.027-0.124-0.022-0.069-0.152-0.555-0.3020.101-0.049
Income Tax Expense 0.021-0.004-0.3774.9060.0040.0121.7120.0050.0290.0160.0290.0120.0650-0.9300.05-0.03-5.4560.0010.0210.0041.979-0.04200-0.128000
Net Income 9.81713.108-1.6467.3625.144-2.531-9.374.6520.6-6.206-1.327-5.252-5.469-3.656-11.053-4.237-6.4732.5682.1060.8460.293-0.489-4.265-0.303-0.868-1.664-4.894-2.5030.723-0.338
Net Income Ratio 0.1550.224-0.030.120.101-0.06-0.2070.1130.017-0.222-0.045-0.226-0.24-0.175-0.605-0.239-0.3640.1060.0920.0370.013-0.027-0.231-0.019-0.069-0.152-0.541-0.3020.101-0.049
EPS 0.520.69-0.0870.390.27-0.13-0.490.240.032-0.33-0.076-0.3-0.31-0.22-0.69-0.26-0.40.160.130.050.02-0.031-0.27-0.019-0.054-0.1-0.31-0.160.055-0.021
EPS Diluted 0.510.69-0.0870.390.27-0.13-0.490.240.031-0.33-0.076-0.3-0.31-0.22-0.69-0.26-0.40.160.130.050.02-0.031-0.27-0.019-0.054-0.1-0.31-0.160.055-0.021
EBITDA 14.76811.749.49612.9976.052.68513.1915.5580.336-2.8834.246-1.281-0.4790.409-3.308-0.1560.9545.722-0.2734.4172.3330.882-0.8161.1190.239-0.638-4.434-1.620.909-0.334
EBITDA Ratio 0.2330.20.1710.2120.1190.0630.2920.1340.009-0.1030.145-0.055-0.0210.02-0.181-0.0090.0540.235-0.0120.1920.1070.05-0.0440.070.019-0.058-0.49-0.1950.127-0.049